Sbir phase II topic 314, title: a vascularized tumor-microenvironment assay for the screening of anti-cancer drugs
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261201500024C
- Awardee
-
Nortis Inc. UEI W2BAEFZVHWZ5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,988,728
Award facts
- Opportunity
-
- BAAN44CM4701411 Solicitation number
- Contract value 100% obligated
- $1,988,728.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 5 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Seattle, WA 98195, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,988,728 |
About this award
This is a Phase II Small Business Innovation Research (SBIR) contract awarded by the National Cancer Institute (NCI), a civilian agency of the U.S. Department of Health and Human Services (HHS), to Nortis Inc., a for-profit manufacturer of biotechnology products and services. The contract, valued at $1,988,728.00, is for the development of a "vascularized tumor-microenvironment assay" to support the screening of anti-cancer drugs. This contract is designated as a Total Small Business set-aside. Nortis Inc. has previously received other prime federal contracts and grants from various NIH institutes for the development of organ-on-a-chip and microphysiological systems for applications in liver toxicology, kidney proximal tubule, and SARS-CoV-2 research.
Quick answers
Who was awarded contract HHSN261201500024C?
HHSN261201500024C was awarded to Nortis Inc. by National Cancer Institute (National Institutes of Health) on September 21, 2015.
How much is contract HHSN261201500024C worth?
The government has obligated $1,988,728 on HHSN261201500024C.
Was contract HHSN261201500024C competed?
The extent of competition for HHSN261201500024C was full and open competition after exclusion of sources. The government received 5 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award